您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (5): 84-89.doi: 10.6040/j.issn.1671-7554.0.2022.1204

• 公共卫生与管理学 • 上一篇    

1990—2019年中国人类免疫缺陷病毒/获得性免疫缺陷综合征流行趋势及疾病负担

张蒙,马伟   

  1. 山东大学齐鲁医学院公共卫生学院流行病学系, 山东 济南 250012
  • 发布日期:2023-05-15
  • 通讯作者: 马伟. E-mail:weima@sdu.edu.cn
  • 基金资助:
    国家重点研发计划(2017YFE0103800);国家科技重大专项(2018ZX10721102-003-004)

Trend and disease burden of human immunodeficiency virus/acquired immunodeficiency syndrome in China from 1990 to 2019

ZHANG Meng, MA Wei   

  1. Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China
  • Published:2023-05-15

摘要: 目的 分析1990—2019年中国人类免疫缺陷病毒/获得性免疫缺陷综合征(HIV/AIDS)疾病流行现状、负担及危险因素变化趋势,预测2020—2030年HIV/AIDS发病和死亡情况。 方法 探讨1990—2019年中国HIV/AIDS疾病的流行现状,通过Joinpoint回归拟合其发病率和疾病负担变化趋势。采用集成嵌套拉普拉斯近似(INLA)的贝叶斯年龄-时期-队列分析(BAPC)方法预测2020—2030年HIV/AIDS发病和死亡趋势。 结果 1990—2019年中国男性HIV/AIDS标化发病率、标化死亡率高于女性,15~19岁、20~24岁标化发病率总体呈增长趋势,75~79岁标化发病率变化幅度最大。1990—2019年中国HIV/AIDS标化发病率、标化伤残调整寿命年(DALYs)率均呈上升趋势,差异具有统计学意义(P均<0.001);归因于危险性行为的标化DALYs率最高。BAPC预测结果显示,2020—2030年中国男性HIV/AIDS标化死亡率呈上升趋势。 结论 中国青少年HIV/AIDS发病风险持续增加,老年群体死亡风险也不容忽视;HIV/AIDS疾病负担呈上升趋势,危险性行为是首要危险因素。未来应针对重点人群采取预防和控制措施。

关键词: 人类免疫缺陷病毒/获得性免疫缺陷综合征, 疾病负担, 危险因素, 时间趋势, 预测

Abstract: Objective To analyze the situation, disease burden and risk factors of human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS)in China from 1990 to 2019 and to forecast the incidence and mortality from 2020 to 2030. Methods The situation of HIV/AIDS in China from 1990 to 2019 was explored and its temporal trend of incidence and disease burden were analyzed with Joinpoint regression. The trend of incidence and mortality from 2020 to 2030 were predicted with Bayesian age-period-cohort(BAPC)model integrated with nested Laplace approximations. Results The age-standardized incidence and mortality rate of HIV/AIDS in China in males were higher than those in females. The age-standardized incidence showed an increasing trend in people aged 15 to 19 years and 20 to 24 years, and showed the largest variation in people aged 75 to 79 years. The age-standardized incidence and disability-adjusted life years(DALYs)rate of HIV/AIDS in China increased from 1990 to 2019 and there were statistically significant differences(P<0.001); the age-standardized DALYs rate of HIV/AIDS attributable to unsafe sex was the highest. The BAPC predicted that the age-standardized mortality rate of HIV/AIDS in China in males would increase from 2020 to 2030. Conclusion The risk of HIV/AIDS incidence in adolescents continues to increase in China and the risk of mortality in elderly should not be ignored. The disease burden of HIV/AIDS shows an increasing trend and unsafe sex is the primary risk factor. In the future, prevention and control measures should be taken for the key population.

Key words: Human immunodeficiency virus/acquired immunodeficiency syndrome, Disease burden, Risk factors, Temporal trend, Prediction

中图分类号: 

  • R181.2
[1] Xu JJ, Han MJ, Jiang YJ, et al. Prevention and control of HIV/AIDS in China: lessons from the past three decades[J]. Chin Med J(Engl), 2021, 134(23): 2799-2809.
[2] GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017[J]. Lancet HIV, 2019, 6(12): e831-e859.
[3] 赵虹琳, 李巧梅, 李婷婷, 等. 2004—2018年中国艾滋病发病与死亡趋势及其年龄-时期-队列模型分析 [J]. 中国全科医学, 2023, 26(4): 409-416. ZHAO Honglin,LI Qiaomei,LI Tingting,et al. AIDS in China from 2004 to 2018:incidence and mortality trends and age-period-cohort effect analysis[J]. Chinese General Practice, 2023, 26(4): 409-416.
[4] Qiao YC, Xu Y, Jiang DX, et al. Epidemiological analyses of regional and age differences of HIV/AIDS prevalence in China, 2004-2016[J]. Int J Infect Dis, 2019, 81: 215-20. doi: 10.1016/j.ijid.2019.02.016.
[5] Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019[J]. Lancet, 2020, 396(10258): 1204-1222.
[6] Jahagirdar D, Walters MK, Novotney A, et al. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the global burden of diseases study 2019[J]. Lancet HIV, 2021, 8(10): e633-e651.
[7] Hu W, Fang L, Zhang H, et al. Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China[J]. Public Health, 2022, 208: 89-97. doi: 10.1016/j.puhe.2022.04.015.
[8] Murray CJL, Lopez AD. Measuring global health: motivation and evolution of the global burden of disease study[J]. Lancet, 2017, 390(10100): 1460-1464.
[9] Ma Y, Cui Y, Hu Q, et al. Long-term changes of HIV/AIDS incidence rate in China and the U.S. population from 1994 to 2019: a join-point and age-period-cohort analysis[J]. Front Public Health, 2021, 9: 652868. doi: 10.3389/fpubh.2021.652868.
[10] Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019[J]. Lancet, 2020, 396(10258): 1223-1249.
[11] Centers for disease control and prevention. Fast facts: preventing intimate partner violence [EB/OL].(2022-10-11)[2022-11-14]. https://www.cdc.gov/violenceprevention/inti-matepartnerviolence/fastfact.html.
[12] Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351.
[13] Riebler A, Held L. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested LaPlace approximations[J]. Biom J, 2017, 59(3): 531-549.
[14] Wang X, Wang Z, Jiang X, et al. A cross-sectional study of the relationship between sexual compulsivity and unprotected anal intercourse among men who have sex with men in shanghai, China[J]. BMC Infect Dis, 2018, 18(1): 465. doi: 10.1186/s12879-018-3360-x.
[15] Zhong F, Lin P, Xu H, et al. Possible increase in HIV and syphilis prevalence among men who have sex with men in Guangzhou, China: results from a respondent-driven sampling survey[J]. AIDS Behav, 2011, 15(5): 1058-1066.
[16] Bor J, Rosen S, Chimbindi N, et al. Mass HIV treatment and sex disparities in life expectancy: demographic surveillance in rural South Africa[J]. PLoS Med, 2015, 12(11): e1001905. doi: 10.1371/journal.pmed.1001905.
[17] Takarinda KC, Harries AD, Shiraishi RW, et al. Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV-infected patient cohort in Zimbabwe: 2007-2010[J]. Int J Infect Dis, 2015, 30: 98-105. doi: 10.1016/j.ijid.2014.11.009.
[18] Trepka MJ, Fennie KP, Sheehan DM, et al. Late HIV diagnosis: differences by rural/urban residence, Florida, 2007-2011[J]. AIDS Patient Care STDS, 2014, 28(4): 188-197.
[19] Zhao H, Liu H, Wang L, et al. Epidemiological characteristics of newly-reported HIV cases among youth aged 15-24 Years-China, 2010-2019[J]. China CDC Wkly, 2020, 2(48): 913-916.
[20] 郭伟贵, 茅乃玲, 沈智勇. 学校艾滋病防控面临的挑战及策略[J]. 实用预防医学, 2020, 27(11): 1403-1405. GUO Weigui, MAO Nailing, CHEN Zhiyong. Challenges and strategies for HIV/AIDS prevention and control in schools[J]. Practical Preventive Medicine, 2020, 27(11):1403-1405.
[21] 刘童童, 陈清峰, 李雨波, 等. 艾滋病防治宣传教育实践与挑战[J]. 中国艾滋病性病, 2021, 27(11): 1179-1181.
[22] 张静, 谢今朝, 刘聪, 等. 2004—2019年广州市艾滋病抗病毒治疗老年患者特征变化趋势: 基于Joinpoint回归的回顾性队列研究[J]. 现代预防医学, 2021, 48(12): 2276-2280. ZHANG Jing, XIE Jinzhao, LIU Cong, et al. Joinpoint regression model analysis on trend characteristics among HIV-infected patients starting antiretroviral treatment in Guangzhou 2004-2019[J]. Modern Preventive Medicine, 2021, 48(12): 2276-2280.
[23] Montano M, Landay A, Perkins M, et al. HIV and aging in the era of ART and COVID-19: symposium overview[J]. J Acquir Immune Defic Syndr, 2022, 89(Suppl 1): s3-s9.
[24] Sun X, Lu F, Wu Z, et al. Evolution of information-driven HIV/AIDS policies in China[J]. Int J Epidemiol, 2010, 39(Suppl 2): ii4-ii13.
[25] Mao Y, Wu Z, Poundstone K, et al. Development of a unified web-based national HIV/AIDS information system in China[J]. Int J Epidemiol, 2010, 39(Suppl 2): ii79-ii89.
[26] 郑灵巧, 陈清峰, 沈洁. 中国艾滋病防治政策与策略发展历程回溯[J]. 中国艾滋病性病, 2019, 25(7): 657-661.
[27] Wang L, Wang L, Norris JL, et al. HIV prevalence and influencing factors analysis of sentinel surveillance among men who have sex with men in China, 2003-2011[J]. Chin Med J(Engl), 2012, 125(11): 1857-1861.
[28] 胡健. 青年男同性恋/双性恋者多性伴行为的社会文化因素[J]. 中国艾滋病性病, 2020, 26(2): 172-174. HU Jian. Sociocultural factors of sexual behaviors with multiple sex partners among young homosexual/bisexual men[J]. Chinese Journal of AIDS & STD, 2020, 26(2): 172-174.
[29] Bao YP, Liu ZM, Li JH, et al. Club drug use and associated high-risk sexual behaviour in six provinces in China[J]. Addiction, 2015, 110(Suppl 1): 11-19.
[30] 韩孟杰, 陈清峰, 徐鹏, 等. 砥砺奋进“十三五”艾滋病防控迈向新征程—我国艾滋病防治回顾与展望[J]. 中国艾滋病性病, 2021, 27(12): 1327-1331.
[31] Hampanda KM, Rael CT. HIV status disclosure among postpartum women in Zambia with varied intimate partner violence experiences[J]. AIDS Behav, 2018, 22(5): 1652-1661.
[32] Su X, Zheng L, Zhang H, et al. Secular trends of acute viral hepatitis incidence and mortality in China, 1990 to 2019 and its prediction to 2030: the global burden of disease study 2019[J]. Front Med(Lausanne), 2022, 9: 842088. doi: 10.3389/fmed.2022.842088.
[1] 宋晗,王振华,韦铎亮,徐凯,李博文,赵鑫. 术前MELD分级对304例急性StandfordA型主动脉夹层患者术后早期结局的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 31-36.
[2] 蔡强,单悌超,吴晗. 临终病情评估单预测临终患者生存期的效果[J]. 山东大学学报 (医学版), 2023, 61(5): 79-83.
[3] 钟璐,薛付忠. 基于贝叶斯网络不确定性推理的肺癌风险预测模型[J]. 山东大学学报 (医学版), 2023, 61(4): 86-94.
[4] 穆彦熹,李金洲,陈康,梁红英,姚亚龙,汪文杰,陈晓. 443例胃癌根治术后发生肺部并发症的危险因素[J]. 山东大学学报 (医学版), 2023, 61(4): 37-41.
[5] 邵长秀,贺青卿,庄晓璇,李小磊,周鹏,岳涛,高远,徐婧,李陈钰,郭浩男,庄大勇. 934例甲状腺微小乳头状癌颈淋巴结部位转移及危险因素[J]. 山东大学学报 (医学版), 2023, 61(2): 57-64.
[6] 巨艳丽,王丽华,成芳,黄凤艳,陈学禹,贾红英. 基于机器学习构建放射性碘治疗疗效的预测模型[J]. 山东大学学报 (医学版), 2023, 61(1): 94-99.
[7] 贺士卿,李皖皖,董书晴,牟婧怡,刘宇莹,魏思雨,刘钊,张家新. 基于数据库构建乳腺癌焦亡相关基因的预后风险模型[J]. 山东大学学报 (医学版), 2022, 60(8): 34-43.
[8] 刘盈,杨淑霞,佘凯丽,程传龙,房启迪,韩闯,崔峰,李秀君. 2019年山东省淄博市居民死因及疾病负担探析[J]. 山东大学学报 (医学版), 2022, 60(6): 114-121.
[9] 姚雪,卢冉冉,孙淑玲,高翠平,肖茹,王书会. 风湿性心脏病患者瓣膜置换术后医院感染风险预测评分模型的构建[J]. 山东大学学报 (医学版), 2022, 60(6): 90-96.
[10] 杨丛品,罗卓野,许秀华,李爱民,郝桂敏. 河北省某医院体检3 512例育龄女性生育选择及压力现状[J]. 山东大学学报 (医学版), 2022, 60(4): 62-67.
[11] 吕岩红,张志勉. 2 809名体检人群中高血压与幽门螺杆菌感染的关联性[J]. 山东大学学报 (医学版), 2022, 60(2): 43-47.
[12] 冯一平,孙大鹏,王显军,纪伊曼,刘云霞. DLNM和LSTM神经网络对临沂市手足口病发病的预测效果比较[J]. 山东大学学报 (医学版), 2022, 60(2): 96-101.
[13] 田庆,刘永鹏,张晶晶,刘洪庆. ARIMA乘积季节模型在山东省肺结核发病预测中的应用[J]. 山东大学学报 (医学版), 2021, 59(7): 112-118.
[14] 吕丽,姜璐,陈诗鸿,庄向华,宋玉文,王殿辉,安文娟,李倩,潘喆. 210例绝经后2型糖尿病发生骨质疏松的相关因素[J]. 山东大学学报 (医学版), 2021, 59(7): 19-25.
[15] 陈丽宇,肖娟,吕仙忠,段宝敏,洪凡真. 影响孕产妇下肢深静脉血栓预后的危险因素分析[J]. 山东大学学报 (医学版), 2021, 59(7): 38-42.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!